Strumento inattivo

Altre lingue Nymox Pharmaceutical Corporation Nasdaq

Azioni

CA67076P1027

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

2023	Nymox Pharmaceutical Corporation riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI
2023	Nymox Pharmaceutical Corporation annuncia la presentazione di una nuova domanda di autorizzazione all'immissione in commercio per NYMOZARFEX (TM) per BPH	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Nymox Pharmaceutical : Form 6-K	13/05
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages	27/03
OTC F-Stocks Holiday Momentum Watchlist (TBRIF, PYRGF, NYMXF, MGDPF)	28/12
Nymox December 27 Message to Shareholders	27/12
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others	30/11
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court	21/11
Nymox: Q3 Earnings Snapshot	15/11
Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Nymox Pharmaceutical : MANAGEMENT’S DISCUSSION AND ANALYSIS - Form 6-K	15/11
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million	09/11
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized	03/11
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023	03/11
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023	03/11
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations	02/11
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting	31/10/23
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting	27/10/23
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review	26/10/23
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	25/09/23
Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	25/09/23
Nymox Reports Completion of $2 Million Private Placement	29/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Nymox Pharmaceutical Corporation Nasdaq

Azioni

CA67076P1027

Altre lingue

Filtri